GrayMatters Health

Meet Dima Lavro, Algorithm Engineer at GrayMatters Health!   With a PhD in Cognitive Neuroscience, Dima brings his passion for neuroscience and innovation to the GMH team. He thrives on exploring new ideas, designing experiments, and testing concepts.   At GMH, Dima develops the algorithms and models behind Prism, working with EEG and MRI signals to enhance their effectiveness. Inspired by the fast-evolving field of algorithms and machine learning, he is passionate about applying these advancements to create meaningful change in mental healthcare.   Outside of the office, Dima is an avid traveler and hiker, with memorable adventures in destinations like Nepal and the Austrian Alps.

A big thank you to Karen Giles, MD, MS of Breakthru Psychiatric Solutions LLC for your amazing explanation of how Prism for PTSD™ works! We appreciate the care you provide to your patients, taking the time to ensure they understand the treatment and its benefits. Your dedication to patient outcomes is clear. https://lnkd.in/dyyJsKPr

What are mental strategies and what is their connection to Prism? Check out our new animation to discover how you can empower your patients on their journey with Prism for PTSD™. https://lnkd.in/dA2gFN7a

The weekend is almost here and Aviv Rubin, Ori Grinshten, and Ayelet Pnueli brought four-legged support to the GMH office today. 🐶

The GMH team enjoyed a fun movie night featuring Inside Out! Joined by the characters Joy, Sadness, Fear, and Anger—and, of course, popcorn—it was the perfect way to unwind and enjoy each other's company, appreciating the ways in which emotions can be explained to the next generation 🍿 With thoughtful productions like this, the future for mental health awareness is bright! Have you seen Inside Out? We’d love to hear your thoughts—what resonated with you most?

Hypervigilance and exaggerated startle responses are core symptoms of PTSD, often keeping patients in a constant state of high alert. In Prism for PTSD™ studies, patients showed significant improvement in these symptoms 3 months following the completion of treatment. This data highlights the potential of Prism for PTSD as a valuable adjunctive therapy in the management of PTSD. https://lnkd.in/dqWTUG97

The end of treatment shouldn’t mean the end of improvement. With Prism for PTSD™, many patients report continued improvement even three months after completing their treatment. By integrating the mental strategies learned in the clinic into their daily routines, Prism equips patients with a practical skill for managing PTSD symptoms. With Prism, treatment is just the beginning.

For clinicians seeking to deepen their understanding of PTSD, check out this webinar from Medscape. This session covers PTSD epidemiology, symptoms, diagnosis, and the crucial role of access to care in clinical practice across various healthcare settings. A big thank you to Medscape, John Krystal, Lori Davis, and Matthew McDonell for providing this important resource and raising awareness about PTSD. It’s a must-watch for healthcare providers committed to improving patient care.

Prof. Eyal Fruchter, from the Israel National PTSD Council and a principal investigator of the Prism for PTSD™ clinical trial, will present the new findings at the ACNP 63rd Annual Meeting on December 9 in Phoenix, Arizona. The multi-center study showed Prism’s potential to treat PTSD, with clinically significant symptom improvement, a low rate of mild adverse events, and high patient retention. Don't miss out! 📅 December 9, 2024 📍 Phoenix, Arizona

As we set our sights on an impactful 2025, the global GMH team came together to strategize, align and bond. There’s nothing quite like the energy created by being together in the same room. A small team with a big mission to help people living with mental illness get back to better.